Achieve Life Sciences, Inc. Increase (Decrease) in Deferred Revenue
Achieve Life Sciences, Inc. (ACHV) reported Increase (Decrease) in Deferred Revenue of -$5.04 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-07-31
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was -$2.10M.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-03-31 was -$2.94M.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$5.04M, a 200.00% decline from fiscal 2015.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for fiscal 2015 was $5.04M.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for fiscal 2012 was -$18.27M.
- Achieve Life Sciences, Inc. increase (decrease) in deferred revenue for fiscal 2011 was -$3.35M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | -$2.10M derived: sum of 3 quarters · filed 2017-07-31 | -$5.04M 10-K · filed 2017-02-23 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$2.10M derived: sum of 2 quarters · filed 2017-07-31 | -$5.04M 10-Q · filed 2016-11-10 | -$11.04M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$5.04M 10-Q · filed 2017-07-31 | -$11.04M derived: sum of 3 quarters · filed 2017-07-31 | -$17.78M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-03-31 | -$2.94M 10-Q · filed 2017-05-15 | -$8.94M derived: sum of 2 quarters · filed 2017-05-15 | -$15.68M derived: sum of 3 quarters · filed 2017-05-15 | |
| 2015-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$12.74M derived: sum of 2 quarters · filed 2017-02-23 | $5.04M 10-K · filed 2017-02-23 | |
| 2015-09-30 | -$6.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $11.04M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $17.78M 10-Q · filed 2016-08-04 | |||
| 2012-12-31 | -$9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$15.37M derived: sum of 2 quarters · filed 2015-03-26 | -$17.34M derived: sum of 3 quarters · filed 2015-03-26 | -$18.27M 10-K · filed 2015-03-26 |
| 2012-09-30 | -$6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$8.19M derived: sum of 2 quarters · filed 2013-11-07 | -$9.13M 10-Q · filed 2013-11-07 | -$9.89M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$2.90M 10-Q · filed 2013-08-08 | -$3.66M derived: sum of 3 quarters · filed 2014-03-11 | -$4.50M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | -$936.00K 10-Q · filed 2013-05-02 | -$1.70M derived: sum of 2 quarters · filed 2014-03-11 | -$2.53M derived: sum of 3 quarters · filed 2014-03-11 | -$3.71M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$1.60M derived: sum of 2 quarters · filed 2014-03-11 | -$2.77M derived: sum of 3 quarters · filed 2014-03-11 | -$3.35M 10-K · filed 2014-03-11 |
| 2011-09-30 | -$831.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$2.00M derived: sum of 2 quarters · filed 2012-11-08 | -$2.59M 10-Q · filed 2012-11-08 | -$4.01M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$1.75M 10-Q · filed 2012-08-02 | -$3.18M derived: sum of 3 quarters · filed 2013-03-07 | -$4.27M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | -$581.00K 10-Q · filed 2012-05-03 | -$2.00M derived: sum of 2 quarters · filed 2013-03-07 | -$3.09M derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$2.51M derived: sum of 2 quarters · filed 2013-03-07 | -$4.91M 10-K · filed 2013-03-07 | |
| 2010-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$3.48M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$2.39M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $26.53M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |